Sinovac Biotech Operating Expenses Growth & History (SVA)

Sinovac Biotech's operating expenses was $752.1M for fiscal 2025.

View full Sinovac Biotech company overview

Sinovac Biotech annual operating expenses history

Sinovac Biotech annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$752.1M$25.9M+3.57%
20242024-12-31$726.2M−$311.1M−29.99%
20232023-12-31$1.04B−$286.9M−21.67%
20222022-12-31$1.32B$566.2M+74.68%
20212021-12-31$758.1M$530.3M+232.78%
20202020-12-31$227.8M$82.8M+57.08%
20192019-12-31$145.0M−$14.6M−9.14%
20182018-12-31$159.6M$50.9M+46.85%
20172017-12-31$108.7M$59.2M+119.42%
20162016-12-31$49.5M$4.2M+9.32%
20152015-12-31$45.3M−$260,000−0.57%
20142014-12-31$45.6M$4.2M+10.28%
20132013-12-31$41.3M−$9.9M−19.40%
20122012-12-31$51.3M$18.9M+58.53%
20112011-12-31$32.3M$2.3M+7.66%
20102010-12-31$30.0M$8.1M+36.63%
20092009-12-31$22.0M

Sinovac Biotech operating expenses trends

Over the last five fiscal years, Sinovac Biotech's operating expenses increased from $227.8M to $752.1M, a change of $524.3M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sinovac Biotech source filings ↗

Community posts

It’s quiet here.

No posts about SVA yet. Start the conversation.

Write the first post